Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $41.5 million.

  • Angiodynamics' Shares Outstanding (Diluted Average) rose 151.51% to $41.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $41.5 million, marking a year-over-year increase of 151.51%. This contributed to the annual value of $40.9 million for FY2025, which is 167.24% up from last year.
  • Latest data reveals that Angiodynamics reported Shares Outstanding (Diluted Average) of $41.5 million as of Q4 2025, which was up 151.51% from $41.2 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Shares Outstanding (Diluted Average) ranged from a high of $41.5 million in Q4 2025 and a low of $38.3 million during Q2 2021
  • Over the past 5 years, Angiodynamics' median Shares Outstanding (Diluted Average) value was $39.7 million (recorded in 2023), while the average stood at $39.8 million.
  • As far as peak fluctuations go, Angiodynamics' Shares Outstanding (Diluted Average) skyrocketed by 95.0% in 2021, and later surged by 190.82% in 2022.
  • Angiodynamics' Shares Outstanding (Diluted Average) (Quarter) stood at $39.1 million in 2021, then grew by 1.12% to $39.5 million in 2022, then grew by 1.85% to $40.2 million in 2023, then rose by 1.75% to $40.9 million in 2024, then grew by 1.52% to $41.5 million in 2025.
  • Its last three reported values are $41.5 million in Q4 2025, $41.2 million for Q3 2025, and $40.9 million during Q2 2025.